Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $283,948 | 77 | 73.4% |
| Travel and Lodging | $54,892 | 102 | 14.2% |
| Consulting Fee | $34,734 | 18 | 9.0% |
| Food and Beverage | $7,629 | 119 | 2.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,480 | 1 | 1.4% |
| Education | $17.18 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $94,936 | 73 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $93,341 | 64 | $0 (2021) |
| Gilead Sciences, Inc. | $87,282 | 46 | $0 (2022) |
| Seagen Inc. | $49,278 | 24 | $0 (2023) |
| Daiichi Sankyo Inc. | $32,067 | 20 | $0 (2023) |
| PUMA BIOTECHNOLOGY, INC. | $14,697 | 18 | $0 (2021) |
| Immunomedics, Inc. | $5,360 | 3 | $0 (2020) |
| Gen-Probe Sales & Service, Inc. | $4,152 | 13 | $0 (2022) |
| EISAI INC. | $3,195 | 4 | $0 (2019) |
| Hologic Sales and Service, LLC | $1,213 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24,473 | 16 | Seagen Inc. ($21,890) |
| 2022 | $97,813 | 66 | Gilead Sciences, Inc. ($65,188) |
| 2021 | $49,601 | 63 | Daiichi Sankyo Inc. ($22,927) |
| 2020 | $51,331 | 47 | AstraZeneca Pharmaceuticals LP ($21,602) |
| 2019 | $89,161 | 64 | Novartis Pharmaceuticals Corporation ($45,476) |
| 2018 | $57,373 | 48 | Novartis Pharmaceuticals Corporation ($33,281) |
| 2017 | $16,949 | 15 | AstraZeneca Pharmaceuticals LP ($10,401) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2023 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $541.80 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $111.15 | General |
| Category: Oncology | ||||||
| 07/22/2023 | Hologic Sales and Service, LLC | FETAL FIBRONECTIN ENZYME IMMUNOASSAY (Device), APTIMA, BTX | Food and Beverage | In-kind items and services | $145.52 | General |
| Category: Diagnostics | ||||||
| 07/21/2023 | Hologic Sales and Service, LLC | FETAL FIBRONECTIN ENZYME IMMUNOASSAY (Device), APTIMA, BTX | Food and Beverage | In-kind items and services | $142.45 | General |
| Category: Diagnostics | ||||||
| 06/06/2023 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: Oncology | ||||||
| 06/06/2023 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $1,046.61 | General |
| Category: Oncology | ||||||
| 06/06/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $57.06 | General |
| Category: Oncology | ||||||
| 05/17/2023 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| Category: Oncology | ||||||
| 05/17/2023 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $1,148.13 | General |
| Category: Oncology | ||||||
| 05/17/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $85.33 | General |
| Category: Oncology | ||||||
| 04/07/2023 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Oncology | ||||||
| 03/29/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2023 | Hologic Sales and Service, LLC | BTX (Device) | Travel and Lodging | In-kind items and services | $501.97 | General |
| Category: Diagnostics | ||||||
| 03/21/2023 | Hologic Sales and Service, LLC | BTX (Device) | Travel and Lodging | In-kind items and services | $422.76 | General |
| Category: Diagnostics | ||||||
| 12/07/2022 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,160.00 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $1,121.41 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $38.65 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Seagen Inc. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,160.00 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $1,155.00 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $467.20 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Seagen Inc. | TUKYSA (Drug) | Travel and Lodging | In-kind items and services | $414.96 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $75.49 | General |
| Category: Oncology | ||||||
| 10/27/2022 | Gen-Probe Sales & Service, Inc. | BTX (Device) | Travel and Lodging | In-kind items and services | $283.98 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 253 | 349 | $70,976 | $16,900 |
| 2021 | 6 | 690 | 1,545 | $289,981 | $104,209 |
| 2020 | 6 | 667 | 1,618 | $281,783 | $78,055 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 197 | $38,021 | $8,507 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 63 | $17,262 | $5,881 | 34.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 18 | 26 | $6,890 | $1,260 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 47 | 47 | $5,875 | $877.08 | 14.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 15 | 16 | $2,928 | $374.36 | 12.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 287 | 926 | $178,718 | $64,788 | 36.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 78 | 154 | $42,196 | $16,842 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 274 | 391 | $48,875 | $16,680 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 21 | 44 | $11,660 | $3,185 | 27.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 13 | 13 | $5,421 | $1,907 | 35.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 17 | 17 | $3,111 | $806.25 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 206 | 949 | $183,157 | $54,117 | 29.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 312 | 499 | $62,375 | $15,304 | 24.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 34 | 42 | $11,508 | $3,484 | 30.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 65 | 76 | $13,908 | $2,791 | 20.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 31 | 33 | $8,745 | $2,030 | 23.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 19 | 19 | $2,090 | $329.20 | 15.8% |
About Dr. Elyse Lower, MD
Dr. Elyse Lower, MD is a Hematology & Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447244843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elyse Lower, MD has received a total of $386,700 in payments from pharmaceutical and medical device companies, with $24,473 received in 2023. These payments were reported across 319 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($283,948).
As a Medicare-enrolled provider, Lower has provided services to 1,610 Medicare beneficiaries, totaling 3,512 services with total Medicare billing of $199,164. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Cincinnati, OH
- Active Since 08/31/2005
- Last Updated 08/08/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447244843
Products in Payments
- Trodelvy (Drug) $91,990
- KISQALI (Drug) $86,144
- LYNPARZA (Drug) $58,749
- TUKYSA (Drug) $49,278
- Enhertu (Drug) $31,167
- FASLODEX (Drug) $10,401
- NERLYNX (Drug) $8,885
- AFINITOR (Drug) $7,530
- Nerlynx (Drug) $5,812
- BTX (Device) $4,858
- Halaven (Drug) $3,195
- ACTHAR (Biological) $1,148
- ENHERTU (Drug) $900.00
- FETAL FIBRONECTIN ENZYME IMMUNOASSAY (Device) $287.97
- TYVASO (Drug) $30.37
- ONGLYZA (Drug) $20.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cincinnati
Dr. David Waterhouse, Md, MD
Hematology & Oncology — Payments: $1.3M
Dr. Alexander Starodub, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $254,325
Dr. James Essell, Md, MD
Hematology & Oncology — Payments: $223,019
Davendra Sohal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $124,378
Dr. Edward Faber, D.o., M.s, D.O., M.S
Hematology & Oncology — Payments: $116,895
Dr. Soumit Basu, M.d. Ph.d, M.D. PH.D
Hematology & Oncology — Payments: $114,168